BLIS Technologies (NZSE:BLT) EV-to-EBIT : 18.62 (As of May. 27, 2024)

View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BLIS Technologies's Enterprise Value is NZ$13.54 Mil. BLIS Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.73 Mil. Therefore, BLIS Technologies's EV-to-EBIT for today is 18.62.

The historical rank and industry rank for BLIS Technologies's EV-to-EBIT or its related term are showing as below:

NZSE:BLT' s EV-to-EBIT Range Over the Past 10 Years
Min: -67.07 Med: -9.75 Max: 191.97
Current: -46.05

During the past 13 years, the highest EV-to-EBIT of BLIS Technologies was 191.97. The lowest was -67.07. And the median was -9.75.

NZSE:BLT's EV-to-EBIT is ranked worse than
100% of 424 companies
in the Biotechnology industry
Industry Median: 10 vs NZSE:BLT: -46.05

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. BLIS Technologies's Enterprise Value for the quarter that ended in Mar. 2024 was NZ$17.27 Mil. BLIS Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.73 Mil. BLIS Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 4.21%.

BLIS Technologies EV-to-EBIT Historical Data

The historical data trend for BLIS Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies EV-to-EBIT Chart

BLIS Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-EBIT

Get a 7-Day Free Trial

39.00

121.05

-16.67

-22.21

23.76

BLIS Technologies Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-16.67	-	-22.21	-	-

Competitive Comparison of BLIS Technologies's EV-to-EBIT

For the Biotechnology subindustry, BLIS Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BLIS Technologies's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's EV-to-EBIT falls into.

BLIS Technologies EV-to-EBIT Calculation

BLIS Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	13.540	/	0.727
	=	18.62

BLIS Technologies's current Enterprise Value is NZ$13.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BLIS Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.73 Mil.

BLIS Technologies (NZSE:BLT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

BLIS Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	0.727	/	17.27344
	=	4.21 %

BLIS Technologies's Enterprise Value for the quarter that ended in Mar. 2024 was NZ$17.27 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BLIS Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NZ$0.73 Mil.

BLIS Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

BLIS Technologies (NZSE:BLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016

Website

https://www.blis.co.nz

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).